Account (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide
- Catalog No. :
- ACAMGN354
- CAS No. :
- 60-92-4
- Molecular Formula :
- C10H12N5O6P
- Molecular Weight :
- 329.21
IUPAC Name:(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide
![(4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide structure diagram](/images/productimg/no-pic.svg)
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g99%$69.00Login to see priceIn stockInquiry
25g99%$272.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide |
|---|---|
| IUPAC Name | (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide |
| MDL No. | MFCD00005845 |
| Molecular Formula | C10H12N5O6P |
| Molecular Weight | 329.21 |
| SMILES | NC1=NC=NC2=C1N=CN2[C@@H]3O[C@@](COP(O4)(O)=O)([H])[C@]4([H])[C@H]3O |
| InChI Key | IVOMOUWHDPKRLL-KQYNXXCUSA-N |
| Synonym | cAMP | bmse000071 | cAMP | Cyclic Monophosphate, Adenosine | 3',5'-cyclic AMP | Adenosine 3',5'-cyclic phosphate | ADENOSINUM CYCLOPHOSPHORICUM | Cyclic AMP | Epitope ID:137352 | Adenosine 3',5'-cyclophosphate | Adenosine Cyclic 3',5' Monophosphate | ADEN |
| CAS No. | 60-92-4 |
| PubChem CID | 6076 |
Safety Data
- Pictogram
- Signal Word
- Danger
- Hazard Statement(s)
- H314
- Precautionary Statement(s)
- P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P321-P363-P405-P501
Synthetic Route by SureRoute
2. ACAMGN354 Molecular Building Block Synthetic Route
![(4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt structure diagram](https://xchemchain-prod-1253699568.cos.ap-guangzhou.myqcloud.com/production/attachments/2026/07/22/98kv/37839-81-9.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIDT0SoARehYSEnT2RxQiomY7TcckkZDlIx%2F20260802%2Fap-guangzhou%2Fs3%2Faws4_request&X-Amz-Date=20260802T053312Z&X-Amz-Expires=86400&X-Amz-SignedHeaders=host&response-content-disposition=attachment%3B%20filename%3D%2237839-81-9.png%22&x-id=GetObject&X-Amz-Signature=0114e081eb47cdf5a56c87931c3c77d8b2e82c9ed043b003f6365f019bb1cee4)
(4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide, sodium salt
Adenosine, cyclic 3′,5′-[hydrogen (S)-phosphate]
Sodium (2R,3R,3aS,7aR,9R,10R,10aS,14aR)-2,9-bis(6-amino-9H-purin-9-yl)-3,10-dihydroxyoctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecine-5,12-bis(olate) 5,12-dioxide